Using the Patient Concerns Inventory in the identification of fatigue following treatment for head and neck cancer

Simon Rogers, Cherith Semple, Gerry Humphris, Derek Lowe, Anastasios Kanatas

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
17 Downloads (Pure)

Abstract

Fatigue has a profound impact on health-related quality of life (HRQOL). The aim of this study was to describe the clinical characteristics and HRQOL of head and neck cancer patients who raised the issue of fatigue on the Patient Concerns Inventory (PCI) at their review consultation. Eight consultants were randomized to use the PCI as part of a cluster-controlled trial. Patients also completed the University of Washington Quality of Life version 4 (UWQOL), EQ-5D-5L (EuroQol Group), and Distress Thermometer questionnaires. The study included 140 patients who attended clinics at a median of 108 (interquartile range 70-165) days after the end of treatment. The PCI item 'fatigue' was the sixth most commonly selected, by 29% (n=40). Those with advanced tumours were more likely to have selected the item (30/84, 36% vs 10/56, 18%; P=0.02), as were those treated with radiotherapy±chemotherapy (34/87, 39% vs 6/53, 11%; P
Original languageEnglish
Pages (from-to)865-872
Number of pages8
JournalInternational Journal of Oral and Maxillofacial Surgery
Volume50
Issue number7
Early online date26 Nov 2020
DOIs
Publication statusPublished (in print/issue) - 1 Jul 2021

Bibliographical note

Funding Information:
This study would not have been possible without the valued contribution and support of the eight consultants who used the PCI in the trial.

Publisher Copyright:
© 2020 International Association of Oral and Maxillofacial Surgeons

Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.

Keywords

  • fatigue
  • head and neck neoplasms
  • needs assessment
  • quality of life
  • surveys and questionnaires

Fingerprint

Dive into the research topics of 'Using the Patient Concerns Inventory in the identification of fatigue following treatment for head and neck cancer'. Together they form a unique fingerprint.

Cite this